About: Otamixaban

Property	Value
dbo:abstract	Otamixaban (INN) is an experimental injectable anticoagulant direct factor Xa inhibitor that was investigated for the treatment for acute coronary syndrome. In 2013, Sanofi announced that it had ended development of the drug candidate after poor performance in a Phase III clinical trial. (en) オタミキサバン（Otamixaban）は、キサバン（xaban）と付くことからも明らかなように、の1種である。CAS登録番号は193153-04-7。 (ja) L'Otamixaban (INN) è un anticoagulante iniettabile inibitore del fattore Xa sperimentale , che fu valutato per il trattamento della Sindrome coronarica acuta . Nel 2013, Sanofi annunciò che interrompeva lo sviluppo del farmaco per scarsi risultati negli studi clinici in fase III (it) Otamixaban é um fármaco que age como inibidor direto do fator Xa. (pt)
dbo:casNumber	193153-04-7
dbo:chEMBL	46618
dbo:fdaUniiCode	S173RED00L
dbo:pubchem	5496659
dbo:thumbnail	wiki-commons:Special:FilePath/Otamixaban.svg?width=300
dbo:wikiPageID	16350944 (xsd:integer)
dbo:wikiPageLength	3363 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1001368397 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Sanofi dbr:Anticoagulant dbc:Direct_Xa_inhibitors dbr:Phase_III_clinical_trial dbr:Acute_coronary_syndrome dbr:Drug_development dbr:International_Nonproprietary_Name dbr:Direct_factor_Xa_inhibitor
dbp:atcPrefix	none (en)
dbp:c	25 (xsd:integer)
dbp:casNumber	193153 (xsd:integer)
dbp:chembl	46618 (xsd:integer)
dbp:chemspiderid	4593439 (xsd:integer)
dbp:h	26 (xsd:integer)
dbp:image	Otamixaban 3D.png (en)
dbp:iupacName	Methyl -2-{3-[aminomethyl]benzyl}-3-{[4-benzoyl]amino}butanoate (en)
dbp:n	4 (xsd:integer)
dbp:o	4 (xsd:integer)
dbp:pubchem	5496659 (xsd:integer)
dbp:smiles	O=C[C@H][C@H]C (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	PFGVNLZDWRZPJW-OPAMFIHVSA-N (en)
dbp:unii	S173RED00L (en)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	462266309 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Antithrombotics dbt:Drugbox dbt:Reflist dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Ebicite dbt:Fdacite dbt:Stdinchicite dbt:Blood-drug-stub
dct:subject	dbc:Direct_Xa_inhibitors
gold:hypernym	dbr:Inhibitor
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatAnticoagulants yago:Agent114778436 yago:Anticoagulant102718259 yago:CausalAgent100007347 yago:Drug103247620 yago:Matter100020827 yago:Medicine103740161 yago:PhysicalEntity100001930 dbo:Drug yago:Substance100020090 umbel-rc:DrugProduct
rdfs:comment	Otamixaban (INN) is an experimental injectable anticoagulant direct factor Xa inhibitor that was investigated for the treatment for acute coronary syndrome. In 2013, Sanofi announced that it had ended development of the drug candidate after poor performance in a Phase III clinical trial. (en) オタミキサバン（Otamixaban）は、キサバン（xaban）と付くことからも明らかなように、の1種である。CAS登録番号は193153-04-7。 (ja) L'Otamixaban (INN) è un anticoagulante iniettabile inibitore del fattore Xa sperimentale , che fu valutato per il trattamento della Sindrome coronarica acuta . Nel 2013, Sanofi annunciò che interrompeva lo sviluppo del farmaco per scarsi risultati negli studi clinici in fase III (it) Otamixaban é um fármaco que age como inibidor direto do fator Xa. (pt)
rdfs:label	Otamixaban (it) オタミキサバン (ja) Otamixaban (en) Otamixaban (pt)
owl:sameAs	freebase:Otamixaban yago-res:Otamixaban wikidata:Otamixaban dbpedia-fa:Otamixaban dbpedia-it:Otamixaban dbpedia-ja:Otamixaban dbpedia-pt:Otamixaban dbpedia-sh:Otamixaban dbpedia-sr:Otamixaban https://global.dbpedia.org/id/4sp2M
prov:wasDerivedFrom	wikipedia-en:Otamixaban?oldid=1001368397&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Otamixaban.svg wiki-commons:Special:FilePath/Otamixaban_3D.png
foaf:isPrimaryTopicOf	wikipedia-en:Otamixaban
is dbo:wikiPageWikiLink of	dbr:Direct_factor_Xa_inhibitors
is foaf:primaryTopic of	wikipedia-en:Otamixaban